Background: Resolvin D1 (RvD1), a member of the specialized pro-resolving lipid mediators family, has a potent anti-inflammatory effect and alleviates tissue damage. The purpose of the current research was to study the effect of RvD1 on CP/CPPS and the underlying mechanisms using a mouse model of experimental autoimmune prostatitis (EAP) mice. Materials and Methods: The EAP mouse model was successfully established, and was used to test the therapeutic effect of RvD1. Hematoxylin-eosin staining and dihydroethidium staining were used to evaluate the histological changes and oxidative stress levels of prostate tissues. Chronic pelvic pain was assessed by applying von Frey filaments to the lower abdomen. The superoxide dismutase enzyme and malondialdehyde levels were detected using enzyme-linked immunosorbent assay (ELISA). The levels of inflammation-related cytokines, including IL-1β, IL-6, and TNF-α were detected by ELISA. Results: RvD1 treatment ameliorated prostatic inflammation and the pelvic pain of EAP mice. RvD1 treatment could inhibit activation of the NLRP3 inflammasome and oxidative stress. RvD1 treatment could activate Nrf2/HO-1 signaling in mice with EAP. Blockade of Nrf2/HO-1 signaling abolished the RvD1-mediated inhibition of oxidative stress, NLRP3 inflammasome activation and the anti-inflammatory effect of RvD1 in EAP. Conclusion: RvD1 treatment can reduce inflammatory cell infiltration in prostate tissue and attenuate pelvic pain associated with EAP by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO-1 pathway. These results provide new insights that RvD1 has the potential as an effective agent in the treatment of EAP.
In statistical learning for survival data, survival trees are favored for their capacity to detect complex relationships beyond parametric and semiparametric models. Despite this, their prediction accuracy is often suboptimal. In this paper, we propose a new method based on super learning to improve the within-node estimation and overall survival prediction accuracy, while preserving the interpretability of the survival tree. Simulation studies reveal the proposed method's superior finite sample performance compared to conventional approaches for within-node estimation in survival trees. Furthermore, we apply this method to analyze the North Central Cancer Treatment Group Lung Cancer Data, cardiovascular medical records from the Faisalabad Institute of Cardiology, and the integrated genomic data of ovarian carcinoma with The Cancer Genome Atlas project.
The case-cohort study design is often used in modern epidemiological studies of rare diseases, as it can achieve similar efficiency as a much larger cohort study with a fraction of the cost. Previous work focused on parameter estimation for case-cohort studies based on a particular statistical model, but few discussed the survival prediction problem under such type of design. In this article, we propose a super learner algorithm for survival prediction in case-cohort studies. We further extend our proposed algorithm to generalized case-cohort studies. The proposed super learner algorithm is shown to have asymptotic model selection consistency as well as uniform consistency. We also demonstrate our algorithm has satisfactory finite sample performances. Simulation studies suggest that the proposed super learners trained by data from case-cohort and generalized case-cohort studies have better prediction accuracy than the ones trained by data from the simple random sampling design with the same sample sizes. Finally, we apply the proposed method to analyze a generalized case-cohort study conducted as part of the Atherosclerosis Risk in Communities Study.
Outcome-dependent sampling (ODS) designs are widely used in epidemiological and biomedical research as cost-effective alternatives to full cohort studies. While existing research has focused on parameter estimation and inference under specific models, survival prediction in ODS settings remains underexplored. In this paper, we propose a gradient boosting machine tailored for survival prediction in studies conducted using general failure-time ODS designs. Our approach integrates a weighting scheme to correct for sampling bias and improves predictive accuracy. We introduce a weighted empirical risk based on the integrated Brier score for hyperparameter tuning and establish its convergence to the corresponding integrated Brier-score risk. The proposed method is evaluated through extensive simulations and applied to the Cancer Incidence and Mortality of Uranium Miners Study, and is shown to have improved effectiveness in survival prediction. This work advances machine learning methods for ODS studies, offering valuable insights for personalized medicine and clinical decision-making in failure-time ODS settings.